Adverum Biotechnologies's total assets for Q1 2025 were $137.65M, a decrease of -23.46% from the previous quarter. ADVM total liabilities were $111.23M for the fiscal quarter, a 1.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.